Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment

Código QR

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment

Xiaohua Li,1 Dalin Song,2 Sean X Leng31Dalian Medical University, Dalian, 2Department of Geriatrics, Qingdao Municipal Hospital, Qingdao, People’s Republic of China; 3Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltim...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Li XH, Song DL, Leng SX
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Alzheimer's disease diabetes mellitus insulin Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/e088bc2e14f3470a93eb113971a55f06
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
por: Subramanian Madhusoodanan, et al.
Publicado: (2008)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
por: Bektaş O, et al.
Publicado: (2015)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai Y, et al.
Publicado: (2015)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

Rehabilitating a brain with Alzheimer's: a proposal
por: Gonzalo Emiliano Aranda-Abreu, et al.
Publicado: (2011)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
por: Wu P, et al.
Publicado: (2015)

Cerebral small vessel disease and Alzheimer’s disease
por: Cai Z, et al.
Publicado: (2015)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
por: Jelcic N, et al.
Publicado: (2014)

Use of short-acting insulin aspart in managing older people with diabetes
por: Eltayeb Marouf, et al.
Publicado: (2009)

Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
por: Fowler NR, et al.
Publicado: (2018)

Spaced Retrieval and Episodic Memory Training in Alzheimer’s Disease
por: Small JA, et al.
Publicado: (2020)

Vitamin E and Alzheimer’s disease: what do we know so far?
por: Browne D, et al.
Publicado: (2019)

Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease
por: Zhang YY, et al.
Publicado: (2013)

Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
por: Adams CD
Publicado: (2020)

RAB10: an Alzheimer’s disease resilience locus and potential drug target
por: Tavana JP, et al.
Publicado: (2018)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

Altered diastolic function and aortic stiffness in Alzheimer’s disease
por: Çalık AN, et al.
Publicado: (2014)

Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
por: Cardoso BR, et al.
Publicado: (2013)

Estrogen receptor α gene polymorphisms and risk of Alzheimer’s disease: evidence from a meta-analysis
por: Cheng D, et al.
Publicado: (2014)

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis
por: Richard A Hansen, et al.
Publicado: (2008)

Hearing difficulty is linked to Alzheimer’s disease by common genetic vulnerability, not shared genetic architecture
por: Fatin N. Zainul Abidin, et al.
Publicado: (2021)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Noll Campbell, et al.
Publicado: (2008)

Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review
por: Liang JH, et al.
Publicado: (2018)

Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease
por: Yin Q, et al.
Publicado: (2020)

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
por: Aydin EY, et al.
Publicado: (2020)

PSEN1 L226F mutation in a patient with early-onset Alzheimer’s disease in Korea
por: Bagyinszky E, et al.
Publicado: (2016)

Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study
por: Davis KL, et al.
Publicado: (2014)

Anti-amyloid aggregation activity of novel carotenoids: implications for Alzheimer’s drug discovery
por: Lakey-Beitia J, et al.
Publicado: (2017)

Alzheimer’s disease and language impairments: social intervention and medical treatment
por: Klimova B, et al.
Publicado: (2015)

Electroencephalography-driven approach to prodromal Alzheimer's disease diagnosis: from biomarker integration to network-level comprehension
por: Moretti DV
Publicado: (2016)

Different durations of cognitive stimulation therapy for Alzheimer’s disease: a systematic review and meta-analysis
por: Chen J, et al.
Publicado: (2019)

Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes
por: Eby EL, et al.
Publicado: (2015)

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
por: Yatawara C, et al.
Publicado: (2021)